Protekt Therapeutics For Profit
Protekt Therapeutics is a drug development company in Israel developing potent and selective oral inhibitors of the kinase PKR for the treatment of Alzheimer’s Disease and other neurodegenerative and neuroinflammatory diseases.
Founded Date:
2015-12-01
Headquarters:
Ness Ziona, HaMerkaz, Israel
Technology:
Neuropharmacology
Employee Number:
1-10
Industry:
NeuroTech